Joto Inc. v. CVS Pharmacy: Voluntary Dismissal in User-Matching Patent Case

📄 View Full Report 📥 Export PDF 🔗 Share ⭐ Save

📋 Case Summary

Case NameJoto Inc. v. CVS Pharmacy, Inc.
Case Number2:26-cv-00108 (EDTX)
CourtEastern District of Texas, Chief Judge Rodney Gilstrap
DurationFeb 13, 2026 – Feb 19, 2026 6 Days
OutcomePlaintiff Voluntary Dismissal — Without Prejudice
Patent at Issue
Accused ProductsCVS Pharmacy’s digital tools & platforms (user/event matching, recommendation capabilities)

Case Overview

The Parties

⚖️ Plaintiff

A patent assertion entity pursuing enforcement of intellectual property rights related to user-matching and recommendation-engine technologies.

🛡️ Defendant

One of the largest pharmacy and retail health companies in the United States, operating thousands of retail locations and a significant digital commerce platform.

The Patent at Issue

This case involved US Patent No. 9,639,608 B2, covering comprehensive user/event matching and recommendation technologies based on awareness of entities, activities, interests, desires, and location. This technology is foundational to modern digital retail and health platforms.

  • US9,639,608 B2 — Comprehensive user/event matching and personalized recommendations
🔍

Developing a recommendation engine?

Check if your user-matching technology might infringe this or related patents before deployment.

Run FTO Check →

The Verdict & Legal Analysis

Outcome

Joto Inc. filed a **Notice of Voluntary Dismissal Without Prejudice** just six days after the complaint was filed. The court accepted the dismissal, ordering that all claims against CVS Pharmacy were dismissed without prejudice, and each party would bear its own costs. No damages were awarded, and no substantive rulings on validity, infringement, or claim construction were reached.

Verdict Cause Analysis

The dismissal without prejudice under Rule 41(a)(1)(A)(i) of the Federal Rules of Civil Procedure is a unilateral plaintiff right exercisable before the defendant serves an answer or files a motion for summary judgment. This “without prejudice” designation means Joto Inc. preserves the right to refile the same infringement claims against CVS Pharmacy in the future. The rapid closure could indicate an early pre-suit settlement, a strategic reassessment, or an intent to refile elsewhere.

Legal Significance

While this dismissal generates no binding precedent, it reflects a broader pattern in patent assertion entity (PAE) litigation involving recommendation-engine and personalization patents. Quick voluntary dismissals often indicate early licensing success or early strategic retreat — both outcomes that shape how defendants and patent holders approach similar cases. For US9,639,608 B2, its claims touching on location-awareness, entity-matching, and behavioral recommendation systems place it squarely within a highly contested technology space.

⚠️

Freedom to Operate (FTO) Analysis

This case highlights critical IP risks in user-matching and recommendation technologies. Choose your next step:

📋 Understand This Case’s Impact

Learn about the specific risks and implications from this litigation.

  • View the patent family and related prior art
  • See which companies are most active in user-matching patents
  • Understand claim construction patterns in this tech area
📊 View Patent Landscape
⚠️
High Risk Area

Location-aware recommendation systems

📋
Active Patent

US9,639,608 B2 remains a risk

Early Dismissal

Often indicates strategic resolution or pivot

✅ Key Takeaways

For Patent Attorneys & Litigators

Rule 41(a)(1)(A)(i) dismissals without prejudice preserve full re-assertion rights when filed before defendant’s answer.

Search related case law →

EDTX and Judge Gilstrap remain premier patent litigation venues. Monitor closely for similar technology assertions.

Explore precedents →
For IP Professionals

US9,639,608 B2 remains an active, unlitigated-to-judgment asset. Monitor for reassertion against retail and health tech defendants.

Track patent activity →

Track Joto Inc. and Rabicoff Law LLC for related filings across multiple defendants in the user-matching and recommendation technology space.

Monitor litigation trends →
🔒
Unlock R&D Team Recommendations
Get actionable IP strategy steps for product teams, including FTO timing guidance and design-around best practices for user-matching tech.
FTO Timing Guidance Design-Around Strategies Patent Risk Vectors
Explore Full Analysis in PatSnap Eureka

Frequently Asked Questions

Ready to Strengthen Your Patent Strategy?

Join 18,000+ IP professionals using PatSnap Eureka to conduct prior art searches, draft patents, and analyse competitive landscapes with AI-powered precision.

PatSnap IP Intelligence Team

Patent Research & Competitive Intelligence · PatSnap

This analysis was produced by the PatSnap IP Intelligence Team — a group of patent analysts, IP strategists, and data scientists who work daily with PatSnap’s global patent database of over 2 billion structured data points across patents, litigation records, scientific literature, and regulatory filings.

The team specialises in tracking landmark litigation outcomes, translating complex court rulings into actionable IP strategy, and identifying the competitive intelligence implications for R&D and legal teams. All case analysis is grounded in primary sources: official court records, USPTO filings, and Federal Circuit opinions.

📊 2B+ Patent Data Points 🌍 120+ Countries Covered 🏢 18,000+ Customers Worldwide ⚖️ Global Litigation Database 🔍 Primary Source Verified

References

  1. USPTO Patent Database — US9,639,608 B2
  2. Eastern District of Texas Court Information
  3. Cornell Legal Information Institute — Federal Rules of Civil Procedure Rule 41
  4. PatSnap — IP Intelligence Solutions for Law Firms

This article is for informational purposes only and does not constitute legal advice. All case information is drawn from publicly available court records. For platform capabilities, visit PatSnap.

⚖️ Disclaimer: This article is for informational purposes only and does not constitute legal advice. The analysis presented reflects publicly available case information and general legal principles. For specific advice regarding patent litigation, FTO analysis, or IP strategy, please consult a qualified patent attorney.